v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 1,021,018 $ 728,715
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 134,845 133,192
Amortization of right-of-use assets 26,678 28,262
Stock-based compensation costs 66,910 58,792
(Gain) loss attributable to equity method investments (note 5) (2,375) 2,716
(Gain) loss on equity investments (note 5) 7,765 (11,429)
Non-cash restructuring expenses (note 11) 0 33,239
Changes in operating assets and liabilities:    
Accounts receivable (71,469) (76,755)
Inventories (48,032) 163,294
Prepaid expenses, net deferred income taxes and other current assets 35,612 (98,976)
Accounts payable, accrued expenses, income taxes payable and other 41,870 96
Net cash provided by (used in) operating activities 1,212,822 961,146
Cash flows from investing activities:    
Purchases of property, plant and equipment (59,280) (74,579)
Patent registration and acquisition costs (7,584) (13,954)
Business acquisitions, net of cash acquired (670) (113,767)
Purchases of investments (note 5) (4,403) (9,692)
Proceeds from exits of investments (note 5) 4,378 250
Proceeds (payments) on maturity of foreign currency contracts 1,227 (11,533)
Net cash provided by (used in) investing activities (66,332) (223,275)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 44,283 25,399
Taxes paid related to net share settlement of equity awards (17,487) (8,336)
Purchases of treasury stock (200,017) (100,007)
Payments of business combination contingent consideration (855) (1,293)
Proceeds from borrowings, net of borrowing costs 0 105,000
Repayment of borrowings (35,000) (535,000)
Dividends paid (233,290) (211,767)
Net cash provided by (used in) financing activities (442,366) (726,004)
Effect of exchange rate changes on cash (9,774) (1,848)
Net increase (decrease) in cash and cash equivalents 694,350 10,019
Cash and cash equivalents at beginning of period 238,361 227,891
Cash and cash equivalents at end of period 932,711 237,910
Supplemental disclosure of cash flow information:    
Income taxes paid, net of refunds 197,835 235,245
Interest paid 21,503 39,787
Fair value of assets acquired, excluding cash 0 38,520
Liabilities assumed 0 (5,401)
Goodwill on acquisition 0 77,712
Fair value of contingent consideration 1,525 4,372
Cash paid for acquisitions $ 1,525 $ 115,060

Source

10-Q PDF
XBRL